Languages
简体中文
繁體中文
English
日本語
한국어
Bahasa Indonesia
Tiếng Việt
Sign In
Send a Release
Products
News
Resources
Contact
Search
Search
Products
News
Resources
Contact
Overview
Content Creation
Distribution
Monitoring & Insights
Influencer Database
Falcon
All Products
Send a Release
News
Products
Resources
Contact
Overview
Latest
Regional
Mainland China
Japan
Korea
Indonesia
Malaysia
Singapore
Thailand
Vietnam
Australia
Industry
Auto & Transportation
Business Technology
Consumer Products & Retail
Consumer Technology
Energy
Entertainment & Media
Environment
Financial Services
General Business
Health
Heavy Industry & Manufacturing
Policy & Public Interest
Sports
Telecommunications
Travel
Food and Beverages
Advertising, Marketing and Media
Exhibition
Real Estate and Furniture
Trending Topics
Earnings
Artificial Intelligence
Virtual Reality (VR)
Co-Working Space
Belt & Road
Blockchain
Investment & Financing
Personnel Announcements
World Economic Forum
COVID-19 / Coronavirus
Live Streaming
New Technologies & New Products
Web Summit
Carbon Neutral
China International Consumer Products Expo
Biotech
Summer Event
Environmental, Social, Governance (ESG)
RE+ 2023
UN Climate Change Conference (COP28)
Embedded World
Lunar New Year
Mobile World Congress (MWC)
IFA 2023
Holiday Season
Consumer Electronics Show (CES)
Canton Fair
Earth Day
Fortune Global 500/ Fortune China 500
Asian Games
China International Import Expo
5G
International Women's Day
Auto Shanghai 2023
World Environment Day
Multimedia
Other Languages
Malaysian
Thai
Public Company News
Send a Release
Resources
Products
News
Contact
Overview
Beyond PR Blog
Media Coffee
Client Stories
White Papers
Events in APAC
Media Room
Send a Release
Contact
Products
Resources
News
Asia Pacific Offices
Request More Information
Alert / Newsletter Subscription
Our Presence on Social Media Sites
FAQs
Send a Release
Products
News
Resources
Contact
Send a Release
Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
Kun Run Biotechnology, Inc.
2009-11-13 20:41
911
Share:
Source: Kun Run Biotechnology, Inc.
Related Stocks:
OTC:KURU
Keywords:
Health Care/Hospital
Share:
Media Room
more
Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
2010-06-17 18:40
Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
2010-04-23 00:20
Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results
2010-03-30 15:39
Related News
VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure
2024-05-04 18:00
1420
United Imaging to Unveil Industry-Leading MRI Advancements at ISMRM 2024
2024-05-04 09:00
2078
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease
2024-05-03 19:00
1588
Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement
2024-05-03 14:47
2662
collection
Share:
Share to wechat: